bumetanide has been researched along with Hemoglobin C Disease in 2 studies
Hemoglobin C Disease: A disease characterized by compensated hemolysis with a normal hemoglobin level or a mild to moderate anemia. There may be intermittent abdominal discomfort, splenomegaly, and slight jaundice.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkowitz, LR | 1 |
| Orringer, EP | 1 |
| Brugnara, C | 1 |
| Kopin, AS | 1 |
| Bunn, HF | 1 |
| Tosteson, DC | 1 |
2 other studies available for bumetanide and Hemoglobin C Disease
| Article | Year |
|---|---|
Cell volume regulation in hemoglobin CC and AA erythrocytes.
Topics: Biological Transport; Bumetanide; Chlorides; Erythrocytes; Erythrocytes, Abnormal; Furosemide; Hemog | 1987 |
Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease.
Topics: Biological Transport; Bumetanide; Electrolytes; Erythrocyte Volume; Erythrocytes; Hemoglobin A; Hemo | 1985 |